We can't find the internet
Attempting to reconnect
17241.1 PFLS-LS
Chemical warheads targeting cancer and inflammatory disorders
Zusammenfassung
Chemical warheads targeting cancer and inflammatory disorders
Weitere Texte
Abstract
PIQUR and UniBas propose to co-develop a novel strategy to produce covalent inhibitors targeting PI3K/mTOR in cancer and inflammation. The project aims to equip PIQUR with currently unexplored technologyies in the PI3K/mTOR field, and allows UniBas to to study selective PI3K/mTOR-dependent disease mechanisms by Chemical Genetics. Central is entry into uncharted IP space, enlargement of the PIQUR portfolio, the implementation of a proprietary kinase targeting platform, and a highly selective validation of PI3K isoforms as pharmaceutical drug targets.
Beteiligte
Matthias Wymann
Kontaktperson
matthias.wymann@unibas.ch
Universität Basel CHE-115.244.907 Matthias Wymann Mattenstrasse 28 4058 Basel BS CH
Doriano Fabbro
Wirtschaftspartner
doriano.fabbro@piqur.com
PIQUR Therapeutics AG Doriano Fabbro Hochbergerstrasse 60C 4057 Basel BS CH
Projektdetails
- Forschungsstelle
- INNOSUISSE
- Projektstatus
- Abgeschlossen
- Projekttyp
- Forschungsprojekt
- Startdatum
- 2014-11-30
- Enddatum
- 2016-05-31
- Bewilligte Gesamtkosten
- CHF 716832.00
- Sektion
- 20 Förderbereich Life Sciences
- NABS Politikbereich
- Industrielle Produktivität und Technologie
Forschungsdisziplinen
- T115 Medical technology 100.0%